Mennen Medical

Company Overview

Snapshot

Founded in January 1963, Mennen Medical operates with 11–50 employees. The company develops patient diagnostic instrumentation and clinical information systems. In April 2019, Mennen Medical acquired SophistiCart Medical.

Business overview

Mennen Medical develops patient diagnostic instrumentation and clinical information systems for hospital-based cardiac catheterization, electrophysiology, and critical care applications. Its monitoring solutions provide department-to-hospital data connectivity tailored to specific institutional requirements. The company serves the health tech and life sciences sector, operating within digital healthcare and medical devices, with a focus on patient remote monitoring, life support, and medical monitors. Mennen Medical's product portfolio includes SophistiCart, XVU, DTR8, aEEG, and BiliCare.

Strategic signal

In August 2024, Mennen Medical ceased to operate. This indicates a significant operational closure for a company that has been active in the health tech and life sciences sector since 1963, signaling a complete exit from the market.

Company Intelligence Q&A

What is the current operational status of Mennen Medical?

Mennen Medical ceased to operate in August 2024, indicating its non-active status in the market.

When was Mennen Medical founded?

Mennen Medical was founded in January 1963.

What was a key acquisition made by Mennen Medical?

In April 2019, Mennen Medical acquired SophistiCart Medical, a company focused on medical solutions.

What type of products does Mennen Medical offer?

Mennen Medical offers patient diagnostic instrumentation and clinical information systems, including products like SophistiCart, XVU, DTR8, aEEG, and BiliCare, for cardiac catheterization, electrophysiology, and critical care applications.

What was Mennen Medical's strategic partnership in March 2009?

In March 2009, Mennen Medical announced a strategic cooperation agreement with LUMEDX.